Julio
Dávila Valls
Investigador en el periodo 2015-2017
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (21)
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection
-
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology, Vol. 42, Núm. 1
2023
-
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
International Journal of Infectious Diseases, Vol. 137, pp. 98-110
-
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Blood Cancer Journal
2022
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
-
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors
American Journal of Hematology, Vol. 97, Núm. 7, pp. 877-884
-
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival
British Journal of Haematology, Vol. 198, Núm. 2, pp. 278-287
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
2021
-
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
British Journal of Haematology, Vol. 192, Núm. 5, pp. 843-852
2020
-
Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large b-cell lymphoma
Cancers, Vol. 12, Núm. 2
-
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792
-
Comprehensive custom ngs panel validation for the improvement of the stratification of b-acute lymphoblastic leukemia patients
Journal of Personalized Medicine, Vol. 10, Núm. 3, pp. 1-21
-
Pembrolizumab as consolidation strategy in patients with multiple myeloma: Results of the GEM-pembresid clinical trial
Cancers, Vol. 12, Núm. 12, pp. 1-13
2018
-
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients
British Journal of Haematology, Vol. 180, Núm. 6, pp. 831-839
2017
-
Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma
Bone Marrow Transplantation, Vol. 52, Núm. 4, pp. 567-569
-
IgM myeloma: A multicenter retrospective study of 134 patients
American Journal of Hematology, Vol. 92, Núm. 8, pp. 746-751
2016
-
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma
Leukemia, Vol. 30, Núm. 10, pp. 2026-2031
-
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice
American Journal of Hematology, Vol. 91, Núm. 6, pp. 575-580
-
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Leukemia and Lymphoma, Vol. 57, Núm. 9, pp. 2071-2076